TickerFacts.

Insight Molecular Diagnostics Inc. (IMDX): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$11.58M
As of 2025-12-31
$17.76M
As of 2026-06-30
-16.6%
3-year compound annual growth
$32.95M2014-12-31: $257.0K2015-12-31: $8.00M2016-12-31: $10.17M2017-12-31: $7.60M2018-12-31: $8.03M2019-12-31: $22.07M2020-12-31: $7.14M2021-12-31: $32.95M2022-12-31: $19.99M2023-12-31: $9.43M2024-12-31: $8.64M2025-12-31: $11.58M$11.58M
2014-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$11.58M+34.1%2026-03-26, Balance as of period end
2024-12-31$8.64M-8.4%2026-03-26, Balance as of period end
2023-12-31$9.43M-52.8%2025-03-24, Balance as of period end
2022-12-31$19.99M-39.3%2024-04-16, Balance as of period end
2021-12-31$32.95Mn/c2023-04-12, Balance as of period end
2020-12-31$7.14M-67.6%2022-03-11, Balance as of period end
2019-12-31$22.07M+174.7%2021-03-19, Balance as of period end
2018-12-31$8.03M+5.7%2020-03-26, Balance as of period end
2017-12-31$7.60M-25.3%2019-04-01, Balance as of period end
2016-12-31$10.17M+27.2%2018-04-02, Balance as of period end
2015-12-31$8.00Mn/m2018-04-02, Balance as of period end
2014-12-31$257.0Kn/a2017-02-27, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$11.58M+34.1%
Biomerica Inc (BMRA)2026-05-31$1.31M-45.5%
Anbio Biotechnology (NNNN)2025-12-31$7.77M-34.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.75M-0.8%
Volitionrx Ltd (VNRX)2025-12-31$1.12M-65.8%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$28.87M+1.8%
Immucell Corp (ICCC)2025-12-31$3.81M+1.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$5.91M+59.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$155.46M-17.8%

Compare IMDX, BMRA, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗